Pharmaceuticals
Company Overview of H-Phar S.A.
Company Overview
H-PHAR SA operates as a pharmaceutical research company in Belgium. It engages in preclinical research for the development of anti-viral applications in the domain of hemorrhagic fever and oncoviruses, and immune-modulator drugs inhibiting graft rejection; clinical development of anti-HIV drugs; and synthesis and evaluation of biological activities of low molecular weight azo-compounds. The company was founded in 2002 and is based in Gosselies, Belgium.
Rue Clément Ader 12
Gosselies , 6041
Belgium
Founded in 2002
Key Executives for H-Phar S.A.
Similar Private Companies By Industry
| Company Name | Region |
| PerkinElmer NV | Europe |
| ERFA SA | Europe |
| Pronota NV | Europe |
| Dafra Pharma International Ltd. | Europe |
| Biotreatment | Europe |
Recent Private Companies Transactions
| Type Date |
Target | |
| No transactions available in the past 12 months. | ||
Most Searched Private Companies
| Company Name | Geographic Region |
| NYC2012, Inc. | United States |
| Bertelsmann AG | Europe |
| Lawyers Committee for Civil Rights Under Law | United States |
| Rush University | United States |
| Greater Houston Partnership | United States |
Post a JobJobs
- Greenville, NC | Vidant Medical CenterPosted: May 15
- Ohio | Boehringer IngelheimPosted: May 05
- Gainesville, FL | AstraZenecaPosted: May 23
- Field, KY | Shire PharmaceuticalsPosted: May 18
Sponsored Financial Commentaries
Sponsored Links
To contact H-Phar S.A., please visit www.h-phar.com. Company data is provided by Capital IQ. Please use this form to report any data issues.
Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.
